Two things are true at once.
๐ง๐ต๐ฒ ๐ณ๐ถ๐ฟ๐๐ ๐ถ๐ ๐๐ต๐ฎ๐ ๐ฝ๐ฟ๐ฒ๐๐ฒ๐ป๐๐ถ๐ผ๐ป ๐ถ๐ ๐๐ต๐ฒ ๐บ๐ผ๐๐ ๐ฑ๐ถ๐๐ฐ๐๐๐๐ฒ๐ฑ ๐๐ป๐ฑ๐ฒ๐ฟ-๐ณ๐๐ป๐ฑ๐ฒ๐ฑ ๐ฐ๐ฎ๐๐ฒ๐ด๐ผ๐ฟ๐ ๐ถ๐ป ๐ต๐ฒ๐ฎ๐น๐๐ต.
Every conference, every investor letter, every white paper agrees we should be investing more upstream. The numbers are not in dispute.
๐ง๐ต๐ฒ ๐๐ฒ๐ฐ๐ผ๐ป๐ฑ ๐ถ๐ ๐๐ต๐ฎ๐ ๐ฎ๐น๐บ๐ผ๐๐ ๐ป๐ผ๐๐ต๐ถ๐ป๐ด ๐๐๐ฟ๐๐ฐ๐๐๐ฟ๐ฎ๐น ๐ต๐ฎ๐ ๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ๐ฑ.
Forty years of consensus, and the prevention share of UK and US health spending has barely moved.
Meanwhile chronic disease keeps growing as a share of total cost, and the founders building real prevention infrastructure are still operating in the most capital-constrained markets - Nairobi, Lagos, Kampala - where there was never any treatment-first model to retrofit.
That gap between consensus and movement is what I've been writing about for the last six months.
I'm writing a book about the prevention economy.
Not a book about wellness or longevity. A book about the economics - fiscal, political, commercial, of who pays for prevention, who is allowed to provide it, and why a category everyone agrees with structurally has so few defenders inside the rooms where the money actually moves.
The book draws on over a decade of building and advising at the edge of health systems, food, and AI-driven personalised health.
Healthy Nibbles from kitchen to ยฃ10m ARR.
Dsions.
And now Well Purposed, where I work with HealthTech founders trying to commercialise prevention into systems that have spent forty years optimising for treatment.
I've updated my LinkedIn header to reflect that this is now a public commitment.
The book is being written through 2026. Publication is targeted for 2027.
Two requests, while the structure is still flexible.
If you're building prevention infrastructure, particularly in markets where the funding conversation is still treatment-first, I'd like to hear from you. Some of the most useful conversations of the last six months have come from quiet messages.
If you know an agent or publisher who is genuinely passionate about prevention, public health, or the structural economics of healthcare - I'd value an introduction. Publication is targeted for 2027; the right editorial partner matters more than the fastest one.
---
I'm Sara. I advise HealthTech founders on the gap between clinical credibility and commercial scale, through Well Purposed. Previously founded Healthy Nibbles (kitchen to ยฃ10M ARR, Queen's Award, B Corp) and Dsions.
Writing ๐๐ฉ๐ฆ ๐๐ณ๐ฆ๐ท๐ฆ๐ฏ๐ต๐ช๐ฐ๐ฏ ๐๐ค๐ฐ๐ฏ๐ฐ๐ฎ๐บ - publication 2027.